The Department shall be provided with comprehensive information on the origin, passage level, and sub-passage history of rabies viruses used in the development and production of rabies vaccines being submitted for approval. The integrity of the rabies virus used in the production of the vaccine shall be maintained without further modification once the vaccine is approved for use in the Department's rabies control program.